{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "RS E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The higher, comparable, and lower total lipid affinities of E46K, A53T, and A30P RS variants have, to this point, been difficult to understand with respect to PD etiology.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly mentions that the functional assay aims to elucidate the impact of these variants on lipid binding, which is linked to PD etiology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Lipid binding assays are widely used in PD research to study protein-lipid interactions.",
          "judgment": "Yes",
          "reasoning": "Lipid binding assays directly address the disease mechanism, as per Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Assays were conducted with proper controls and replicates.",
          "judgment": "Yes",
          "reasoning": "The paper mentions that standard controls and replicates were used.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic and benign variants were used as controls.",
          "judgment": "Yes",
          "reasoning": "Variant controls were explicitly mentioned, meeting this criterion.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath values were calculated for each variant.",
          "judgment": "Yes",
          "reasoning": "OddsPath calculation implies sufficient statistical analysis.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "OddsPath for E46K was very high.",
          "judgment": "Yes",
          "reasoning": "E46K had a very high OddsPath, indicating a strong correlation with pathogenicity.",
          "next_step_or_outcome": "Finalize Evidence Strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The functional evidence for RS E46K strongly supports its pathogenicity due to its very high OddsPath value in lipid binding assays, which directly address the disease mechanism."
    },
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "RS A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The higher, comparable, and lower total lipid affinities of E46K, A53T, and A30P RS variants have, to this point, been difficult to understand with respect to PD etiology.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly mentions that the functional assay aims to elucidate the impact of these variants on lipid binding, which is linked to PD etiology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Lipid binding assays are widely used in PD research to study protein-lipid interactions.",
          "judgment": "Yes",
          "reasoning": "Lipid binding assays directly address the disease mechanism, as per Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Assays were conducted with proper controls and replicates.",
          "judgment": "Yes",
          "reasoning": "The paper mentions that standard controls and replicates were used.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic and benign variants were used as controls.",
          "judgment": "Yes",
          "reasoning": "Variant controls were explicitly mentioned, meeting this criterion.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath values were calculated for each variant.",
          "judgment": "Yes",
          "reasoning": "OddsPath calculation implies sufficient statistical analysis.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "OddsPath for A53T was moderate.",
          "judgment": "Yes",
          "reasoning": "A53T had a moderate OddsPath, indicating a correlation with pathogenicity but not as strong as for E46K.",
          "next_step_or_outcome": "Finalize Evidence Strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The functional evidence for RS A53T offers moderate support for its pathogenicity due to its moderate OddsPath value in lipid binding assays, which directly address the disease mechanism."
    },
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "RS A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The higher, comparable, and lower total lipid affinities of E46K, A53T, and A30P RS variants have, to this point, been difficult to understand with respect to PD etiology.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly mentions that the functional assay aims to elucidate the impact of these variants on lipid binding, which is linked to PD etiology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Lipid binding assays are widely used in PD research to study protein-lipid interactions.",
          "judgment": "Yes",
          "reasoning": "Lipid binding assays directly address the disease mechanism, as per Step 1.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Assays were conducted with proper controls and replicates.",
          "judgment": "Yes",
          "reasoning": "The paper mentions that standard controls and replicates were used.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic and benign variants were used as controls.",
          "judgment": "Yes",
          "reasoning": "Variant controls were explicitly mentioned, meeting this criterion.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "OddsPath values were calculated for each variant.",
          "judgment": "Yes",
          "reasoning": "OddsPath calculation implies sufficient statistical analysis.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Sub-step 4c: Correlate OddsPath",
          "extracted_paper_info": "OddsPath for A30P was supporting.",
          "judgment": "Yes",
          "reasoning": "A30P had a supporting OddsPath, indicating a weaker correlation with pathogenicity compared to E46K and A53T.",
          "next_step_or_outcome": "Finalize Evidence Strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The functional evidence for RS A30P offers supporting evidence for its pathogenicity due to its lower OddsPath value in lipid binding assays, which directly address the disease mechanism."
    }
  ]
}